GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzychem Lifesciences Corp (XKRX:183490) » Definitions » Market Cap

Enzychem Lifesciences (XKRX:183490) Market Cap : ₩78,928 Mil (As of Apr. 10, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Enzychem Lifesciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Enzychem Lifesciences's share price for the quarter that ended in Dec. 2024 was ₩1425. Enzychem Lifesciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 80 Mil. Therefore, Enzychem Lifesciences's market cap for the quarter that ended in Dec. 2024 was ₩113,768 Mil.

Enzychem Lifesciences's quarterly market cap declined from Jun. 2024 (₩158,916 Mil) to Sep. 2024 (₩120,075 Mil) and declined from Sep. 2024 (₩120,075 Mil) to Dec. 2024 (₩113,768 Mil).

Enzychem Lifesciences's annual market cap increased from Dec. 2022 (₩139,497 Mil) to Dec. 2023 (₩154,650 Mil) but then declined from Dec. 2023 (₩154,650 Mil) to Dec. 2024 (₩113,768 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Enzychem Lifesciences's Enterprise Value for Today is ₩-32,137 Mil.


Enzychem Lifesciences Market Cap Historical Data

The historical data trend for Enzychem Lifesciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzychem Lifesciences Market Cap Chart

Enzychem Lifesciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 869,255.88 457,390.20 139,496.64 154,649.99 113,767.73

Enzychem Lifesciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 154,649.99 160,179.28 158,915.90 120,074.85 113,767.73

Competitive Comparison of Enzychem Lifesciences's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Enzychem Lifesciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzychem Lifesciences's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzychem Lifesciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Enzychem Lifesciences's Market Cap falls into.


;
;

Enzychem Lifesciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Enzychem Lifesciences's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=₩1425*79.837
=₩113,768

Enzychem Lifesciences's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₩1425*79.837
=₩113,768

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enzychem Lifesciences  (XKRX:183490) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Enzychem Lifesciences Market Cap Related Terms

Thank you for viewing the detailed overview of Enzychem Lifesciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzychem Lifesciences Business Description

Traded in Other Exchanges
N/A
Address
27 Gangnamdae-ro Seocho-gu, 10th Floor, aT Center, Seoul, KOR, 135-280
Enzychem Lifesciences Corp develops and produces APIs and functional health foods. It manufactures veterinary medicine tablets, capsules, syrups, injections, ointments, solutions for the diagnosis and prevention of various diseases. The company is also developing drugs to treat chemotherapy-induced neutropenia, chemo-radiation therapy-induced oral mucositis, asthma, psoriasis, rheumatoid arthritis, and others.

Enzychem Lifesciences Headlines

No Headlines